EP1408946A4 - Histondeacetylaseinhibitoren - Google Patents

Histondeacetylaseinhibitoren

Info

Publication number
EP1408946A4
EP1408946A4 EP02719311A EP02719311A EP1408946A4 EP 1408946 A4 EP1408946 A4 EP 1408946A4 EP 02719311 A EP02719311 A EP 02719311A EP 02719311 A EP02719311 A EP 02719311A EP 1408946 A4 EP1408946 A4 EP 1408946A4
Authority
EP
European Patent Office
Prior art keywords
histone deacetylase
deacetylase inhibitors
inhibitors
histone
deacetylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02719311A
Other languages
English (en)
French (fr)
Other versions
EP1408946A2 (de
Inventor
Hsuan-Yin Lan-Hargest
Robert J Kaufman
Norbert L Wiech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Circagen Pharmaceutical LLC
Original Assignee
Circagen Pharmaceutical LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/812,944 external-priority patent/US6495719B2/en
Priority claimed from US09/812,945 external-priority patent/US7312247B2/en
Priority claimed from US10/025,947 external-priority patent/US8026280B2/en
Application filed by Circagen Pharmaceutical LLC filed Critical Circagen Pharmaceutical LLC
Publication of EP1408946A2 publication Critical patent/EP1408946A2/de
Publication of EP1408946A4 publication Critical patent/EP1408946A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP02719311A 2001-03-27 2002-03-25 Histondeacetylaseinhibitoren Withdrawn EP1408946A4 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US812940 1985-12-23
US81294001A 2001-03-27 2001-03-27
US09/812,944 US6495719B2 (en) 2001-03-27 2001-03-27 Histone deacetylase inhibitors
US812944 2001-03-27
US812945 2001-03-27
US09/812,945 US7312247B2 (en) 2001-03-27 2001-03-27 Histone deacetylase inhibitors
US25947 2001-12-26
US10/025,947 US8026280B2 (en) 2001-03-27 2001-12-26 Histone deacetylase inhibitors
PCT/US2002/008836 WO2002076941A2 (en) 2001-03-27 2002-03-25 Histone deacetylase inhibitors

Publications (2)

Publication Number Publication Date
EP1408946A2 EP1408946A2 (de) 2004-04-21
EP1408946A4 true EP1408946A4 (de) 2004-06-09

Family

ID=27487458

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02719311A Withdrawn EP1408946A4 (de) 2001-03-27 2002-03-25 Histondeacetylaseinhibitoren

Country Status (4)

Country Link
EP (1) EP1408946A4 (de)
AU (1) AU2002250401A1 (de)
CA (1) CA2442366C (de)
WO (1) WO2002076941A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (de) 2001-09-10 2003-03-12 Lunamed AG Darreichungsformen mit verlängerter Wirkstofffreisetzung
AU2003226408B2 (en) * 2002-04-15 2007-06-14 Sloan-Kettering Institute For Cancer Research Combination therapy for the treatment of cancer
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
US7842835B2 (en) 2003-07-07 2010-11-30 Georgetown University Histone deacetylase inhibitors and methods of use thereof
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa
WO2006029818A2 (en) * 2004-09-16 2006-03-23 Dsm Ip Assets B.V. Cosmetic compositions containing an hydroxamic acid compound optionally in combination with a retinoid
AU2006270322A1 (en) 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0620823D0 (en) 2006-10-19 2006-11-29 Univ London Histone deacetylase inhibitors
JP2019189648A (ja) * 2019-07-08 2019-10-31 国立大学法人東京農工大学 シス桂皮酸類縁体、重力屈性調節剤
CN110523541B (zh) * 2019-09-04 2021-09-28 中南大学 一种烷基硫醚基乙基羟肟酸药剂及其制备方法与应用
CN114805235B (zh) * 2022-05-09 2024-04-23 江苏中旗科技股份有限公司 一种多取代异恶唑烷酮及其中间体的合成制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886278A (en) * 1973-08-22 1975-05-27 Mead Johnson & Co Ammonium carboxylate sebum inhibition process
JPS6054339A (ja) * 1983-09-05 1985-03-28 Kuraray Co Ltd 不飽和カルボン酸エステルの製造方法
EP0405788A2 (de) * 1989-06-29 1991-01-02 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Di-tert-butyl(hydroxi)phenylthio-substituierte Hydroxamsäurederivate
WO1998001423A1 (en) * 1996-07-09 1998-01-15 Smithkline Beecham S.P.A. 5-indolyl-2,4-pentadienoic acid derivatives useful as inhibitors of bone resorption
WO2000020370A1 (en) * 1998-10-01 2000-04-13 Allergan Sales, Inc. 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110955A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Metabolically stabilized oxyalkylene esters and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886278A (en) * 1973-08-22 1975-05-27 Mead Johnson & Co Ammonium carboxylate sebum inhibition process
JPS6054339A (ja) * 1983-09-05 1985-03-28 Kuraray Co Ltd 不飽和カルボン酸エステルの製造方法
EP0405788A2 (de) * 1989-06-29 1991-01-02 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Di-tert-butyl(hydroxi)phenylthio-substituierte Hydroxamsäurederivate
WO1998001423A1 (en) * 1996-07-09 1998-01-15 Smithkline Beecham S.P.A. 5-indolyl-2,4-pentadienoic acid derivatives useful as inhibitors of bone resorption
WO2000020370A1 (en) * 1998-10-01 2000-04-13 Allergan Sales, Inc. 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MANFRED JUNG ET AL: "Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 42, no. 22, 4 November 1999 (1999-11-04), pages 4669 - 4679, XP002144226, ISSN: 0022-2623 *
PATENT ABSTRACTS OF JAPAN vol. 009, no. 184 (C - 294) 30 July 1985 (1985-07-30) *
RICHON V M ET AL: "A CLASS OF HYBRID POLAR INDUCERS OF TRANSFORMED CELL DIFFERENTIATION INHIBITS HISTONE DEACETYLASES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, no. 6, 17 March 1998 (1998-03-17), pages 3003 - 3007, XP001120542, ISSN: 0027-8424 *
SCHMIDT K ET AL: "INHIBITORS OF HISTONE DEACETYLASE SUPPRESS THE GROWTH OF MCF-7 BREAST CANCER CELLS", ARCHIV DER PHARMAZIE, VCH VERLAGSGESELLSCHAFT MBH, WEINHEIM, DE, vol. 332, no. 10, 1999, pages 353 - 357, XP000985303, ISSN: 0365-6233 *

Also Published As

Publication number Publication date
AU2002250401A1 (en) 2002-10-08
CA2442366C (en) 2012-09-25
WO2002076941A3 (en) 2004-02-12
CA2442366A1 (en) 2002-10-03
EP1408946A2 (de) 2004-04-21
WO2002076941A2 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU8212901A (en) Deacetylase inhibitors
IL164006A0 (en) Inhibitors of histone deacetylase
HK1072365A1 (en) Inhibitors of histone deacetylase
AU2002243402A1 (en) Inhibitors of histone deacetylase
EG25655A (en) Benzamide derivatives useful as histone deacetylase inhibitors
PL374970A1 (en) Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
GB0226855D0 (en) Histone deacetylase inhibitors
IL164002A0 (en) Sulfonyl-derivatives as novel inhibitors of histone deacetylase
HK1080465A1 (zh) 作為組蛋白脫乙酰酶新穎抑制劑的磺酰基氨基衍生物
HUP0402370A3 (en) Pharmaceutical compositions containing cyclooxigenase-2 inhibitor and histone deacetylase inhibitor combination
AU2002362030A8 (en) Methods for inhibiting deacetylase activity
AU2003247390A1 (en) Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
AU2003243285A1 (en) Histone deacetylase inhibitors based on trihalomethylcarbonyl compounds
GB0316313D0 (en) Methods for specifically inhibiting histone deacetylase-4
EG24516A (en) Peptide deformylase inhibitors
ZA200408315B (en) Peptide deformylase inhibitors
AU2003243272A1 (en) Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1408946A4 (de) Histondeacetylaseinhibitoren
AU2003296960A8 (en) Peptide deformylase inhibitors
EP1383729A4 (de) Peptiddeformylaseinhibitoren
SI1443967T1 (sl) Kombinacije inhibitorja ciklooksigenaze-2 in inhibitorja histon deacetilaze
TWI346661B (en) Inhibitors of histone deacetylase
EP1515956A4 (de) Peptiddeformylaseinhibitoren
AU2002329443A1 (en) Histone deacetylase 9

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031024

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040427

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041103